Evidence map›Paper›PMID 32506365›Full record

ArticleCEN case reports2020

Bartter syndrome representing digenic-based salt-losing tubulopathies presumably accelerated by renal insufficiency.

Ryusuke Umene, Mineaki Kitamura, Hideyuki Arai, Kazuki Matsumura, Yuka Ishimaru, Kanenori Maeda, Tadashi Uramatsu, Yoko Obata, Takayasu Mori, Eisei Sohara and 2 more

Open access · greenAbstract readCase Reports
In one paragraph

Article in CEN case reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 95% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Ryusuke UmeneDepartment of Nephrology, JCHO Isahaya General Hospital, Nagasaki, Japan.
Mineaki KitamuraDepartment of Nephrology, Nagasaki University School of Medicine Graduate School of Biomedical Sciences, 1-12-4 Sakamoto, Nagasaki, 852-8102, Japan. mkitamura-ngs@umin.ac.jp.ORCID 0000-0002-0003-8645
Hideyuki AraiDepartment of Nephrology, JCHO Isahaya General Hospital, Nagasaki, Japan.
Kazuki MatsumuraDepartment of Nephrology, JCHO Isahaya General Hospital, Nagasaki, Japan.
Yuka IshimaruDepartment of Nephrology, JCHO Isahaya General Hospital, Nagasaki, Japan.
Kanenori MaedaKen-ai-kai Maeda Clinic, Nagasaki, Japan.
Tadashi UramatsuDepartment of Nephrology, Nagasaki University School of Medicine Graduate School of Biomedical Sciences, 1-12-4 Sakamoto, Nagasaki, 852-8102, Japan.
Yoko ObataDepartment of Nephrology, Nagasaki University School of Medicine Graduate School of Biomedical Sciences, 1-12-4 Sakamoto, Nagasaki, 852-8102, Japan.
Takayasu MoriDepartment of Nephrology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan.
Eisei SoharaDepartment of Nephrology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan.
Shinichi UchidaDepartment of Nephrology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan.
Tomoya NishinoDepartment of Nephrology, Nagasaki University School of Medicine Graduate School of Biomedical Sciences, 1-12-4 Sakamoto, Nagasaki, 852-8102, Japan.
Nagasaki University · JPTokyo Medical and Dental University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Bartter syndrome and Gitelman syndrome (GS) are autosomal recessive disorders usually caused by homozygous or compound heterozygous mutations in causative genes. In some patients, these two syndromes cannot be discriminated based on clinical features or mutation type; thus, a single disease concept, salt-losing tubulopathies (SLTs), has been used instead. Despite the existence of several SLT causative genes, cases of digenic heterozygous mutations in two different genes are extremely rare. Here, we report the case of a 36-year-old woman with renal insufficiency and hypokalemia caused by an SLT. To evaluate the SLT phenotype, we performed next-generation sequencing (NGS) with a gene panel including SLC12A3, SLC12A1, CLCNKB, and CLCNKA as well as laboratory examinations and diuretic loading tests. The results of the diuretic loading tests were consistent with a GS phenotype, while the NGS results showed that the patient had heterozygous mutations in SLC12A1 and CLCNKB. Both genes have been associated with BS, suggesting that the SLT was caused by digenic heterozygous mutations in two different genes. To date, only a few SLT cases caused by digenic heterozygous mutations in two different genes have been reported. The digenic SLT phenotype in the patient was presumably accelerated by moderate renal insufficiency.

Indexed as

AdultBartter SyndromeChloride ChannelsDiagnosis, DifferentialDrug Therapy, CombinationFebuxostatFemaleGitelman SyndromeGout SuppressantsHeterozygoteHumansHyperuricemiaHypokalemiaMutationPhenotypePotassium ChlorideChloride ChannelsCLCNKB protein, humanFebuxostatGout SuppressantsPotassium ChlorideSLC12A1 protein, humanSolute Carrier Family 12, Member 1Bartter syndromeCLCNKBSalt-losing tubulopathiesSLC12A1

Identifiers

PMID32506365
PMCPMC7502106
OpenAlexW3033197699

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.